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Abstract From time immemorial, mushrooms have been
valued by humankind as a culinary wonder and folk medi-
cine in Oriental practice. The last decade has witnessed the
overwhelming interest of western research fraternity in
pharmaceutical potential of mushrooms. The chief medici-
nal uses of mushrooms discovered so far are as anti-oxidant,
anti-diabetic, hypocholesterolemic, anti-tumor, anti-cancer,
immunomodulatory, anti-allergic, nephroprotective, and
anti-microbial agents. The mushrooms credited with success
against cancer belong to the genus Phellinus, Pleurotus,
Agaricus, Ganoderma, Clitocybe, Antrodia, Trametes,
Cordyceps, Xerocomus, Calvatia, Schizophyllum, Flammu-
lina, Suillus, Inonotus, Inocybe, Funlia, Lactarius, Alba-
trellus, Russula, and Fomes. The anti-cancer compounds
play crucial role as reactive oxygen species inducer, mitotic
kinase inhibitor, anti-mitotic, angiogenesis inhibitor, topoi-
somerase inhibitor, leading to apoptosis, and eventually
checking cancer proliferation. The present review updates
the recent findings on the pharmacologically active com-
pounds, their anti-tumor potential, and underlying mecha-
nism of biological action in order to raise awareness for
further investigations to develop cancer therapeutics from
mushrooms. The mounting evidences from various research
groups across the globe, regarding anti-tumor application of
mushroom extracts unarguably make it a fast-track research
area worth mass attention.
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Introduction
Mushrooms have been regarded as gourmet cuisine across
the globe since antiquity for their unique taste and subtle
flavor. Recently, it has been discovered that many mush-
room species are miniature pharmaceutical factories pro-
ducing hundreds of novel constituents with miraculous
biological properties. They have a long history of use in
Oriental medicine, but their legendary effects in promotion
of good health and vitality are being supported by con-
temporary studies only. Of late, mushrooms have emerged
as wonderful source of nutraceuticals, anti-oxidants, anti-
cancer, prebiotic, immunomodulating, anti-inflammatory,
cardiovascular, anti-microbial, and anti-diabetic (Barros
et al. 2007; Sarikurkcu et al. 2008; Wang et al. 2004; Kim
et al. 2007; Synytsya et al. 2009). The ongoing research
projects are aimed to promote mushrooms as new genera-
tion ‘‘biotherapeutics’’.
Cancer is a leading cause of death worldwide. The
current anti-cancer drugs available in market are not target
specific and pose several side-effects and complications in
clinical management of various forms of cancer, which
highlights the urgent need for novel effective and less-toxic
therapeutic approaches. In this context, some prized
mushrooms with validated anti-cancer properties and their
active compounds are of immense interest. Numerous
clinical trials have been conducted to assess the benefits
of using commercial preparations containing medicinal
mushroom extracts in cancer therapy. Their potential uses
individually and as adjuncts to cancer therapy have
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emerged. Mushrooms are known to complement chemo-
therapy and radiation therapy by countering the side-effects of
cancer, such as nausea, bone marrow suppression, anemia, and
lowered resistance. Recently, a number of bioactive molecules,
including anti-tumor agents, have been identified from various
mushrooms (Fig. 1). The bioactive compounds of mushrooms
include polysaccharides, proteins, fats, ash, glycosides, alka-
loids, volatile oils, tocopherols, phenolics, flavonoids, carote-
noids, folates, ascorbic acid enzymes, and organic acids. The
active components in mushrooms responsible for conferring
anti-cancer potential are lentinan, krestin, hispolon, lectin,
calcaelin, illudin S, psilocybin, Hericium polysaccharide A and
B (HPA and HPB), ganoderic acid, schizophyllan, laccase, etc.
(Fig. 2). Polysaccharides are the best known and most potent
mushroom-derived substances with anti-tumor and immuno-
modulating properties. The polysaccharide, b-glucan is the
most versatile metabolite due to its broad spectrum biological
activity. These b-glucans consist of a backbone of glucose
residues linked by b-(1 ? 3)-glycosidic bonds, often with
attached side-chain glucose residues joined by b-(1 ? 6)
linkages (Chen and Seviour 2007). Their mechanisms of
action involve their being recognized as non-self molecules,
so the immune system is stimulated by their presence.
Hispolon, an active polyphenol compound, is known to
possess potent anti-neoplastic properties and potentiate the
cytotoxicity of chemotherapeutic agents. The scientific
investigations to back the claims have gained momentum
in recent years. Findings suggest that some mushrooms in
combination with commercial anti-cancer drugs work in
synergy as an effective tool for treating drug-resistant can-
cers. In this study, the mechanisms underlying apoptosis
induced by medicinal mushrooms are summarized (Fig. 3).
This compilation is expected to provide new insights into the
possible therapeutic use of the mushroom extracts against
different cancers. These results are significant in that they
provide a mechanistic framework for further exploration of
the use of bioactive compounds as novel anti-tumor agents.
The purpose of the present review is to summarize the
available information and to reflect the current status of this
research area with a view for future direction.
Anti-cancer uses of mushrooms
Genus Phellinus
Phellinus is a genus of mushrooms belonging to the family
Hymenochaetaceae. Phellinus linteus has anti-tumor,
Fig. 1 Some medicinal mushrooms with anti-cancer potential
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immunomodulating and anti-metastasis properties owing to
its b-(1 ? 3) linked glycan (Baker et al. 2008). The extract
of P. linteus is reported to contain antimutaganic activities
and play a role in the prevention of cancer by induc-
ing NAD(P)H:quinone oxidoreductase and glutathione
S-transferase activities. Hispolon, the phenolic compound
extracted from this mushroom has potential to induce
apoptosis of breast- and bladder-cancer cell (Lu et al.
2009). A protein-bound polysaccharide from this mush-
room induces G2/M phase arrest and apoptosis in SW480
human colon cancer cells (Li et al. 2004). It has also anti-
inflammatory and anti-angiogenic activities (Kim et al.
Fig. 3 Anti-cancer mechanism of mushroom bioactive compounds
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2004a). Phellinus linteus methanol extract and its fractions,
viz., methylene chloride, ethyl acetate, and n-butanol,
have the potential for anti-angiogenic effects through
the inhibition of human umbilical vein endothelial cells
(HUVECs) proliferation, migration and assembly into
capillary-like structures as well as in vivo angiogenesis.
These findings indicate the potential for the use of the
mushroom extract in stimulated angiogenesis, such as
inflammation and tumor development (Lee et al. 2010).
Huang et al. (2011) evaluated the anti-cancer effect of a
mycelial culture of P. linteus and elucidated its potential
mechanism in vivo. Human hepatoma (Hep3B) cell-trans-
planted mice when administered the mushroom extract
daily for 8 weeks, a significant reduction in tumor size and
increase in T cell numbers; IL-12, IFN-c and TNF-a
secretion; NK cell activity and phagocytic ability were
observed. Therefore, increased numbers of CD4? cells
could have been caused by greater numbers of dendritic
cells and macrophages in the spleen. Furthermore, the
activation of dendritic cells and macrophages resulted in
increased IL-12 secretion, which could up-regulate NK cell
activation. Thus, P. linteus extract may provide a potential
therapeutic approach for both immunomodulatory and anti-
tumor effects. Li et al. (2011) studied the heavily glycos-
ylated protein, proteoglycan purified from P. linteus to
determine its possible anti-tumor effect on human cancer
cells and mechanisms involved. Cell inhibition assay
showed that proteoglycan has an anti-proliferative effect on
human hepatocellular liver carcinoma (HepG2), Human
colon adenocarcinoma (HT-29), human lung cancer (NCI-
H 460) and human breast adenocarcinoma (MCF-7) cells.
When HT-29-bearing mice were treated with 100 mg/kg
proteoglycan, there was relative increase in spleen and
thymus weights, the plasmatic immunoglobulin receptor
pIgR and IgA levels were significantly increased. Mea-
surement by ELISA showed a notable decrease in plas-
matic prostaglandin E2 (PGE2), regenerating islet-derived
protein 4 (Reg IV), epidermal growth factor receptor
(EGFR), and (protin kinase B) Akt concentrations. The
results suggest that proteoglycan acts as an immunopo-
tentiator partly through protecting T cells from escaping
PGE2 attack and enhancing the mucosal IgA response, and
as a direct inhibitor by disrupting the Reg IV/EGFR/Akt
signaling pathway.
Song et al. (2008) deciphered the anti-cancer effects of
Phellinus igniarius. The ethanolic extract from the fruiting
body of P. igniarius was used to evaluate the anti-prolif-
erative and anti-metastatic effects in human hepatocarci-
noma (SK-Hep-1) and rat heart vascular endothelial (RHE)
cells. The extract inhibited the proliferation of both cell
lines in a dose-dependent manner, and the IC50 values at
48 h were 72 and 103 lg/mL for SK-Hep-1 cells and RHE
cells, respectively. Ethanol extract at 25 lg/mL completely
inhibited matrigel-induced tube formation in RHE cells.
Importantly, the extract at concentration 25 or 50 lg/mL
in combination with oxaliplatin (Oxa) or 5-fluorouracil
(5-FU) synergistically inhibited the proliferation of SK-Hep-1
cells. These results demonstrate the potential of P. igniarius
ethanol extract as an adjuvant for chemotherapy.
The downregulation of MDM2, the proto-oncogene
inhibiting the tumor-suppressor function of p53 is consid-
ered an attractive cancer therapeutic strategy (Lu et al.
2009). Hispolon extracted from Phellinus species induce
epidermoid and gastric cancer-cell apoptosis. Regardless of
p53 status, hispolon inhibited breast- and bladder-cancer
cell growth. Hispolon treatment elevated p21 concentra-
tion, a cyclin-dependent kinase inhibitor and degraded
MDM2, a negative regulator of p21 by ubiquitination.
Studies indicated that cells with higher ERK1/2 activity
were more sensitive to hispolon. Crucial role of hispolon in
ubiquitination and downregulation of MDM2 via MDM2-
recruited activated ERK1/2 was reported, projecting the
phenolic compound as a potential anti-tumor agent in
breast and bladder cancers.
Genus Pleurotus
Lavi et al. (2006) reported that an aqueous polysaccharide
extract from Pleurotus ostreatus induces anti-proliferative
and pro-apoptotic effects on HT-29 colon cancer cells. A
novel water-soluble polysaccharide (POPS-1) was obtained
from the fruiting bodies of P. ostreatus by hot-water extrac-
tion, ethanol precipitation, and fractionation by DEAE-cel-
lulose ion exchange and Sepharose CL-6B gel filtration
chromatography. Cytotoxicity assay showed POPS-1 pre-
sented significantly higher anti-tumor activity against HeLa
tumor cell in vitro, in a dose-dependent manner, and exhibited
significantly lower cytotoxicity to human embryo kidney
293T cells than HeLa tumor cells compared with anticancer
drug 5-fluorouracil. The results suggest POPS-1 may be
considered as a potential candidate for developing a novel
low-toxicity anti-tumor agent (Tong et al. 2009).
Li et al. (2008a) isolated a homodimeric 32.4 kDa lectin
from fresh fruiting bodies of the mushroom Pleurotus
citrinopileatus. The lectin exerted potent anti-tumor
activity in mice bearing sarcoma 180, and caused approx-
imately 80% inhibition of tumor growth when administered
intraperitoneally at 5 mg/kg daily for 20 days.
Wong et al. (2007) studied the in vitro anti-proliferative
activities of the water-soluble polysaccharides extracted
from the fruiting body and mycelium of a novel edible
mushroom Pleurotus tuber-regium. Fruiting body extract
showed the strongest cytotoxicity (approximate IC50
25 lg/mL) and exerted effective anti-proliferative activity
at 200 lg/mL against human acute promyelocytic leuke-
mia cells (HL-60). Both polysaccharide extracts induced
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apoptosis in HL-60 cells with an increase in the ratio of
Bax/Bcl-2. Analysis from flow cytometry and western blot
demonstrated that mycelium extract caused G2/M arrest in
HL-60 cells by lowering the Cdk1 expression, while
fruiting body caused S arrest in the HL-60 cells by a
depletion of Cdk2 and an increase in cyclin E expression.
Genus Agaricus
Agaricus blazei Murill has been conventionally used as a
health food for the prevention of cancer. Agaricus blazei
Murrill extracts have immunomodulatory, anti-carcino-
genic and anti-mutagenic properties as studied by its action
on clastogenicity induced by cyclophosphamide (CP) in
mice (Delmanto et al. 2001). Agaricus bisporus lectin
(ABL) and Agaricus polytricha protein (APP) are stable
immune stimulants, for health food and pharmaceutical
utilization (Chang et al. 2007). In vitro, A. bisporus extract
can suppress aromatase activity and prevent breast-cancer
cell proliferation. The broth fraction of A. blazei, when
examined on the growth of human prostate cancer inhibited
cell proliferation in both androgen-dependent and andro-
gen-independent prostate cancer cell lines. The broth of
A. blazei induced lactate dehydrogenase leakage in three
cancer cell lines, whereas the activities of caspase 3 and the
DNA fragmentation were enhanced the most in androgen-
independent PC3 cells. The protein expressions of apop-
tosis-related molecules were elevated by the broth of
A. blazei in PC3 cells. Oral supplementation with the broth
of A. blazei (with the higher ratio of b-glucan) significantly
suppressed tumor growth without inducing adverse effects
in severe combined immunodeficient mice with PC3 tumor
xenograft. Tumor xenografts from A. blazei-fed mice
showed decreased proliferating cell nuclear antigen-posi-
tive cells and reduced tumor microvessel density (Yu et al.
2009). Akiyama et al. (2011) studied the effects of agari-
tine, a hydrazine-derivative from hot-water extract of
A. blazei Murrill on human leukemic monocyte lymphoma
(U937) cells. Agaritine induced DNA fragmentation,
annexin V expression, and cytochrome c release. Caspase-
3, 8, and 9 activities are gradually increased after agaritine
treatment. These results suggest that agaritine moderately
induces apoptosis in U937 cells. Agaricus blazei has been
used as an adjuvant in cancer chemotherapy and various
types of anti-leukemic bioactive components have been
extracted from it. MTT and tritiated thymidine incorpora-
tion assays were used to evaluate the in vitro anti-leukemic
effects. The most potent extract was further investigated
using human promyelocytic leukemia (NB-4) cells-bearing
nude mice. Kim et al. (2009) reported that the extract
JAB80E70 showed the most potent tumor-selective growth
inhibitory activity against human leukemia NB-4 and
K-562 cells. DNA fragmentation assays and cell death
detection by ELISA showed that the fraction induces
apoptosis in NB-4 cells. Adams et al. (2008) evaluated the
effects of A. bisporus extract in vivo and its major com-
ponent, conjugated linoleic acid on prostate cancer cell
lines in vitro, respectively. DU145 and PC3 prostate tumor
size and tumor cell proliferation were decreased in nude
mice treated with mushroom extract. Microarray analysis
of tumors identified significant changes in gene expression
in the mushroom-fed mice as compared to controls. The
conjugated linoleic acid inhibited proliferation in the
prostate cancer cell lines in vitro.
Lentinula edodes
Shiitake mushrooom, Lentinula edodes produces lentinan,
a b-glucan known to suppress leukemia cell proliferation.
The ethanol extract of this mushroom significantly
decreased cell proliferation of CH72 cells, whereas it could
not change the proliferative response of the non-tumori-
genic keratinocyte (C50) cell line. Cell cycle analysis
demonstrated that L. edodes extract induced a transient G1
arrest, with no changes observed in C50 cells (Gu and
Belury 2005).
Trametes versicolor or Coriolus versicolor
The turkey tail mushroom or cloud mushroom, Trametes
versicolor or Coriolus versicolor has been studied to have
anti-tumor property against many types of cancers. Hsieh
and Wu (2001) studied that ethanolic extracts of Yunzhi, a
proprietary dietary supplement prepared from extracts of
T. versicolor reduces the growth of hormone responsive
prostate cancer LNCaP cell growth. The polysaccharo-
peptide in the extract raises the possibility that Yunzhi may
be considered as an adjuvant therapy in the treatment of
hormone responsive prostate cancer; additionally, it may
have chemopreventive potential to restrict prostate tumor-
igenic progression from the hormone-dependent to the
hormone-refractory state. Chu et al. (2002) reviewed that
the growth of several human cancer cell lines, viz., gastric
cancer (7907), lung cancer (SPC), leukemia (MCL), and
lymphoma (SLY)-was markedly inhibited by a crude
C. versicolor extract at 1 mg/mL after 72 h of incubation. The
polysaccharide peptide krestin of T. versicolor has poten-
tial to be used as an adjuvant in breast cancer prevention
(Standish et al. 2008). The polysaccharide of this mush-
room has been demonstrated to inhibit the proliferation of
cancer cells in vitro and in vivo, examined on the human
hepatoma cancer (QGY) cell lines. These results showed
that the polysaccharide inhibited the proliferation in low
concentrations (20 mg/L) and the IC50 value was 4.25 mg/L.
Apoptosis and significant decrease in the expression of
the cell cycle-related genes (p53, Bcl-2, and Fas,) in these
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cells following treatment, indicate that the polysaccharide
can be a potential candidate in cancer therapy (Cai et al.
2010).
Grifola frondosa
Grifola frondosa, commonly known as the dancing mush-
room or Maitake is regarded to impart vitality to health. A
b-glucan purified from G. frondosa enhances the efficacy
of anti-cancer agent cisplatin, checking the decrease in the
number of immunocompetent cells, viz. macrophages, DCs
and NK cells in cisplatin-treated mice (Masuda et al. 2009).
A chemically sulfated polysaccharide (S-GAP-P) derived
from water-insoluble polysaccharide of G. frondosa
mycelia was investigated for its anti-cancer effects alone
and in combination with 5-fluorouracil (5-FU) on human
gastric carcinoma (SGC-7901) cells. Results showed that
S-GAP-P inhibited SGC-7901 cells growth in a dose-
dependent manner and induced cell apoptosis. The com-
bination of S-GAP-P (10–50 lg/mL) with 1 lg/mL 5-FU
resulted in a significant inhibition on SGC-7901 cells
growth. The results confirm that S-GAP-P has evident anti-
cancer activity through apoptotic induction and could sig-
nificantly accelerate the anti-cancer activity of 5-FU (Shi
et al. 2007). Cui et al. (2007) investigated the biological
function of a novel polysaccharide-peptide GFPPS1b, iso-
lated from cultured mycelia of G. frondosa GF9801.
GFPS1b has anti-tumor activity which significantly inhib-
ited the proliferation of human gastric adenocarcinoma
(SGC-7901 cells), whereas slightly influenced the growth
of human normal liver (L-02) cell line. When treated with
GFPS1b, SGC-7901 cells succumbed to apoptotis as evi-
denced from the loss of villus and appearance of apoptotic
bodies on the cell surface, volume reduction, and chro-
matin condensation. The results of flow cytometry analysis
and annexin V-PI assay showed that the SGC-7901 cell
cycle was arrested in the G2/M phase. The apoptotic
machinery was associated with drop in mitochondrial
trans-membrane potential, up-regulation of Bax, down-
regulation of Bcl-2, and activation of caspase-3.
Genus Ganoderma
Ganoderma, commonly known as Lingzhi or Reishi, also
called mushroom of immortality, belonging to family
Ganodermataceae has been traditionally administered
throughout Asia for centuries as a cancer treatment.
Ganoderma lucidum exhibits anti-cancer effect alone or in
combination with chemotherapy and radiotherapy (Pillai
et al. 2010). The effects of ethanol extracts of G. lucidum
on the growth of human gastric carcinoma (AGS) cell line
were investigated which showed decrease in their viabil-
ity.The treatment induced the expression of proteins such
as death receptor 5 and tumor necrosis factor-related
apoptosis-inducing ligand, which further triggered the
activation of caspase-8 and the cleavage of Bid. The
increase in apoptosis induced by the extract was correlated
with activation of caspase-9 and -3, downregulation of IAP
family proteins such as XIAP and survivin, and concomi-
tant degradation of poly (ADP-ribose) polymerase. The
results indicated that EGL induces the apoptosis of AGS
cells through a signaling cascade of death receptor-medi-
ated extrinsic, as well as mitochondria-mediated intrinsic,
caspase pathways which are associated with inactivation of
the Akt signal pathway (Jang et al. 2010). Chen and Zhong
(2011) reported the inhibition of tumor invasion and
metastais by ganoderic acid T, a lanostane triterpenoid
G. lucidum. Ganoderic acid T promoted cell aggregation,
inhibited cell adhesion, and surpressed cell migration with
a dose-dependent manner in human colon tumor cell lines
of HCT-116 p53?/? and p53-/-. GA-Me was found to
possess remarkable cytotoxicity on human colon carci-
noma (HCT-116) cells in a dose-dependent manner. The
expression of anti-tumor protein p53 in GA-Me treated
tumor cells was increased in a time dependent manner.
Among the pro-apoptotic proteins, Bax was up-regulated,
whereas the expression of Bcl-2 was not significantly
changed, thus the ratio of Bax/Bcl-2 was increased. Fur-
thermore, GA-Me reduced mitochondrial transmembrane
potential, released cytochrome c and increased caspase 3
activity during the induced apoptotic process. Our findings
show that the anti-cancer bioactivity of GA-Me was med-
iated by induced apoptosis, resulting from mitochondrial
dysfunctions. Zhou et al. (2011) suggested that GA-Me
may be a novel promising agent for the treatment of human
colon carcinoma cells by mitochondrial pathway manipu-
lation. Liu and Zhong (2010) investigated the effects of a
pair of positional isomer of ganoderic acids, ganoderic acid
Mf (GA-Mf) and ganoderic acid S (GA-S) on induction of
HeLa cells apoptosis. The results demonstrate that both
isomers decreased cell population growth on various
human carcinoma cell lines by MTT assay, while GA-Mf
had better selectivity between normal and cancer cells.
Flow cytometry results and cell cycle arresting phases
show that, compared with GA-S, GA-Mf was more effi-
cient in inducing apoptosis. Treatment of HeLa cells with
each isomer decreased the mitochondrial membrane
potential and caused the release of cytochrome c from
mitochondria into the cytosol, causing stimulation of cas-
pase-3 and caspase-9 activity was observed. The Bax/Bcl-2
ratio was also increased in GA-treated HeLa cells. A native
glycopeptide, LZ-D-4 purified from the fruiting bodies of
G. lucidum, and its sulfated derivative, LZ-D showed anti-
tumor test in vitro against mouse lymphocytic leukemia
(L1210) cell (Ye et al. 2009). The dichloromethane extract
G. lucidum possessing flavonoids, terpenoids, phenolics,
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and alkaloids has anti-human papillomavirus 16 (HPV 16)
E6 oncoprotein activity. Epidermoid cervical carcinoma
(CaSki) cells when treated with the crude dichloromethane
extracts HPV 16 E6 production was suppressed (Lai et al.
2010). Hsu et al. (2008) studied the anti-tumor effects of
Ganoderma tsugae extracts on colorectal adenocarcinoma
cell proliferation. Tumorigenesis study in nude mice
revealed the extracts caused tumor shrinkage. In vitro and
in vivo experiments showed that colorectal adenocarci-
noma cells are inhibited by induction of G2/M cell cycle
arrest. It may be through downregulation of cyclin A and
B1 and up-regulation of p21 and p27. Also, no significant
physiological changes as a result of treatment with
G. tsugae extracts were observed in the animal model.
Purified recombinant fungal immunomodulatory protein
from G. tsugae (reFIP-gts) has anti-telomerase effects in
human lung adenocarcinoma (A549) cells. Liao et al.
(2008) demonstrated that reFIP-gts-treated lung cancer
cells undergo premature cellular senescence and are
arrested at G1 phase. The reFIP-gts- treated A549 cells
grew slowly and formed significantly fewer cell colonies.
Hericium erinaceus
Hericium erinaceus or commonly known as Lions mane
has attracted great attention owing to its anti-tumor and
immunomodulatory effect (Wang et al. 2004). Lee and
Hong (2010) demonstrated that H. erinaceus acts as an
enhancer to sensitize doxorubicin (Dox)-mediated apopto-
tic signaling by reducing c-FLIP expression via JNK acti-
vation and enhancing intracellular Dox accumulation via
the inhibition of NF-jB activity. Kim et al. (2011) inves-
tigated the anti-tumor effects of the extracts of this mush-
rooms in Balb/c mice transplanted with CT-26 colon
cancer cells. The b-glucan rich hot-water obtained by
boiling and microwaving, when injected daily for 2 weeks,
significantly reduced tumor weights by 38 and 41%,
respectively. Tumor regressions were associated with
increase in natural killer cells and tumor necrosis factors.
The pro-angiogenic factors, including vascular endothelial
growth factor (VEGF), cyclooxygenase 2 (COX-2), and
5-lipoxygenase (5-LOX) were also significantly reduced in
mRNA and protein expression by tumor genes. Reduced
COX-2 and 5-LOX expression further triggered the inhi-
bition of neo-angiogenesis inside the tumors. It was con-
cluded that induction of NK activity, activation of
macrophages, and inhibition of angiogenesis all contribute
to the mechanism of reduction of tumor size.
Cordyceps militaris
Rao et al. (2010) purified bioactive compounds from
Cordyceps militaris extracts which displayed potent growth
inhibition on nitric oxide, tumor necrosis factor-a, and
interleukin-12 production from LPS/IFN-c-stimulated
macrophages, along with anti-proliferation effect against
human cancer cells, viz. prostate (PC-3), colon 205 and
hepatoma (HepG2) cells. Kim et al. (2010) investigated the
effects of polysaccharide cordlan isolated from C. militaris
on dendritic cell maturation. Cordlan induce phenotypic
maturation of dendritic cells as demonstrated by the ele-
vated expressions of CD40, CD80, CD86, MHC-I and
MHC-II molecules. Also, cordlan increased phosphoryla-
tion of ERK, p38, and JNK, and nuclear translocation of
NF-jB p50/p65, which were main signaling molecules
down-stream from TLR4. Defect of dendritic cell matura-
tion in tumor microenvironments is an important immu-
nological problem limiting the success of cancer
immunotherapy. Cordyceps militaris extracts significantly
induced level of IL-18 transcription via enhancing of P1
promoter region in mouse brain and liver and activated the
IFN-c production in mouse leukemic monocyte macro-
phage cell line (RAW 264.7). The result indicates its
potential as an immune activator or anti-cancer drug (Kim
et al. 2008). Park et al. (2009) investigated the anti-tumor
effect of C. militaris in NCI-H406 cell-transplanted nude
mice. After feeding an aqueous solution of C. militaris
extracts in NCI-H460 cell-xenografted nude mice for
4 weeks, C. militaris shrunk tumors and increased mouse
lifespan, suggesting that C. militaris was effective in
treating tumors in nude mice. Treatment with cordycepin
from C. militaris significantly inhibited human leukemia
cell growth in a concentration-dependent manner by
inducing apoptosis. This induction was associated with
generation of reactive oxygen species (ROS), mitochon-
drial dysfunction, activation of caspases, and cleavage
of poly (ADP-ribose) polymerase protein. Cordycepin
induces apoptosis of human leukemia cells through a sig-
naling cascade involving a ROS-mediated caspase pathway
(Jeong et al. 2011).
Boletus badius or Xerocomus badius
Theanine (c-glutamylethylamide) having anti-tumor activ-
ity is produced from Xerocomus badius by submerged
fermentation (Li et al. 2008b). L-theanine has synergistic
effect on the anti-tumor activities of doxorubicin, anthra-
cyclines, cisplatin, and irinotecan. Consequently, the
modulating effect of theanine on the efficacy of anti-tumor
agents is expected to be applicable in clinical cancer
chemotherapy.
Calvatia utriformis
Calvatia utriformis or Handkea utriformis or commonly
known as puffballs belonging to Lycoperdaceae family has
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been reported to possess anti-oncogenic properties. Lam
et al. (2001) reported high anti-proliferative activity toward
breast cancer cells by an ubiquitin-like peptide isolated
from C. utriformis fruit-bodies. Ng et al. (2003) isolated a
novel ribosome-inactivating protein calcaelin having
translation-inhibiting and anti-mitogenic activities from
C. utriformis. Calcaelin reduced the viability of breast
cancer cells. Strong antibiotic activity of calvatic acid and
some of its analogs against gastric cancer pathogen Heli-
cobacter pylori has been reported (Coetzee and van Wyk
2009).
Schizophyllum commune
Schizophyllum commune or commonly known as split-gill
mushroom belongs to family Schizophyllaceae. Schizo-
phyllan, a non-ionic, water-soluble homopolysaccharide
consisting of a linear chain of b-D-(1-3)-gluco-pyranosyl
groups and b-D-(1-6)-glucopyranosyl groups produced by
S. commune ATCC 38548 has attracted attention in the
recent years in pharmaceutical industry as immunomodu-
latory and anti-neoplastic agent (Kumari et al. 2008).
Flammulina velutipes
Flammulina velutipes is an edible mushroom, commonly
known as winter mushroom, velvet foot or enoki, falling
under Physalacriaceae family. A fungal immunomodula-
tory protein (FIP-fve), an activator of human T lympho-
cytes purified from F. velutipes has shown anti-tumor
effect on oral administration in murine hepatoma model
(Chang et al. 2010). From the aqueous extract of fruit
bodies of F. velutipes, flammulin, an anti-tumor substance,
was purified. A stable hemagglutinin was isolated from the
fruiting bodies of this mushroom, which inhibits prolifer-
ation of leukemia L1210 cells (Ng and Ngai 2006). Water-
based extracts of F. velutipes was identified as novel
anti-breast-cancer agents. It could markedly inhibit growth
of (estrogen receptor) ER? (MCF-7) and ER- (MDA-MB-
231) breast cancer cells. The extract induced an excep-
tionally rapid apoptosis on both types of cancer cells. The
degree of cytotoxicity on ER- breast cancer cells was very
high, whereas the ER- breast cancer cells are inhibited by
about 99%, following FVE treatment (Gu and Leonard
2006).
Suillus placidus
Irofulven or 6-hydroxymethylacylfulvene is a novel semi-
synthetic anti-tumor agent derived from the sesquiterpene
mushroom toxin illudin S of Suillus placidus. Human liver
cancer cells (HepG2 cells, Hep3B cells, and SK-Hep-1)
were preferentially killed by suillin. Liu et al. (2009) found
for the first time that suillin induces apoptosis in HepG2
cells as characterized by DNA fragmentation, phosphati-
dyl-serine externalization, activation of caspase-3, -8, and
-9, depolarization of mitochondrial membrane potential, as
well as release of cytochrome c into the cytosol. Suillin
also causes significant increases in the protein levels of Fas
death receptor, adaptor FADD protein, pro-apoptotic pro-
tein Bad and a decline of Bid.
Inonotus obliquus
Inonotus obliquus (Chaga mushroom) belonging to
Aphyllophoromycetodeae, one of the widely known
medicinal mushrooms, has been used to treat various
cancers in Russia and most of Baltic countries for many
centuries. Hot-water and ethanol extract of I. obliquus has
ability to induce apoptosis in human colon cancer (DLD-
1) cells by prevention of reactive oxygen species (ROS)-
induced tissue damage (Hu et al. 2009). Youn et al.
(2009) examined the anti-proliferative effects of water
extract of I. obliquus extract on murine melanoma (B16-
F10) cells. The extract not only inhibited the growth of
B16-F10 cells by arresting cell cycle at G0/G1 phase and
causing apoptosis, but also induced cell differentiation.
These effects were associated with the down-regulation
of pRb, p53 and p27 expression levels, and further
showed that I. obliquus extract resulted in a G0/G1 cell
cycle arrest with reduction of cyclin E/D1 and Cdk 2/4
expression levels. Furthermore, the anti-tumor effect of
I. obliquus extract was assessed in vivo in Balb/c mice.
Intraperitoneal administration of I. obliquus extract sig-
nificantly inhibited the growth of tumor mass in B16-F10
cells implanted mice, resulting in a 3-fold inhibition at
dose of 20 mg/kg/day for 10 days. The ethanolic extract
of sclerotium and fruiting body of I. obliquus elicited
significant anti-tumor activity, 74.6 and 44.2%, respec-
tively (Yong et al. 2011).
Inocybe umbrinella
Psilocybin or magic mushrooms contain the psycho-
active compound psilocybin. Moderate doses (0.2 mg/kg)
of the hallucinogen psilocybin treatment demonstrated a
significant reduction in anxiety, mood improvement and,
spirit lift in patients battling cancer. This study estab-
lished the feasibility and safety of administering moderate
doses of psilocybin to patients with advanced-stage
cancer and anxiety (Grob et al. 2011). A novel lectin
extracted from the toxic mushroom Inocybe umbrinella
inhibits proliferation of tumor HepG2 and MCF7 cells
(Zhao et al. 2009).
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Coprinus comatus
The shaggy ink cap mushroom, Coprinus comatus
belonging to Agaricomycetideae was evaluated for its anti-
cancer potential. The IC50 value of the mushroom ethyl
acetate extract was only 32 lg/mL. The extract signifi-
cantly affected IjBa phosphorylation in a dose-dependent
manner. The effect of ethyl acetate extract was comparable
to the effect of curcumin, a known NF-jB pathway
inhibitor. Also, the ethyl acetate extract inhibited the
activity of IKK complex, at close to 90% as compared to
the control of the untreated sample. The results promise
that the mushroom extract can be an effective therapy for
malignant estrogen-independent breast cancer (Asatiani
et al. 2011). Zaidman et al. (2008) studied the selective
inhibition of prostate cancer LNCaP cells by ethanol and
ethyl acetate extracts of this mushroom. It was observed
that this extract inhibits dihydrotestosterone-induced
LNCaP cell viability and causes a G1 phase arrest. These
findings suggested the therapeutic mechanism of the
extract as androgen receptor or non-androgen receptor
mediated.
Funlia trogii
Aqueous extract of the mycelia of Funlia trogii extract
shows good anti-tumor toxicity against a range of
tumor cell lines (Rashid et al. 2011). A variety of
biological assays were used to show that a 4 h exposure
of HT29, LNCaP, PC3, MCF-7 and MDA-MB-231
tumor cells to extract (0.5–5.0 mg/mL) resulted in
significant cytotoxicity. In a clonogenic assay, IC50
values were found to range from 0.4 to 0.72 mg/mL;
exposing fibroblast cells to the extract resulted in no
cell death, whereas proliferating endothelial cells were
killed. When tumors grown in immune compromised
mice were injected intratumourally with extract (5 mg/mL
twice a week for two weeks), a 9 day tumor-growth delay was
observed.
Lactarius flavidulus
The Japanese mushroom Lactarius flavidulus mycelial
culture has anti-cancer properties. The polysaccharides
extracted from this mushroom when administered intra-
peritoneally into white mice at a dosage of 300 mg/kg
inhibited the growth of Sarcoma 180 by 100%. Wu et al.
(2011) isolated a dimeric 29.8-kDa lectin from dried
L. flavidulus fruit bodies. The lectin suppressed prolifera-
tion of HepG2 and L1210 cells with an IC50 of 8.90 lM
and 6.81 lM, respectively.
Genus Clitocybe
Some members of genus Clitocybe belonging to Trichol-
mataceae family have anti-cancer potential. An immuno-
modulatory protein CNL belonging to the ricin B-like
lectin superfamily synthesized by Clitocybe nebularis has
anti-proliferative effect which appears to be elicited by
binding to carbohydrate receptors on human leukemic T
cells. CNL also has potential therapeutic applications in
treating hematopoietic malignancies (Pohleven et al. 2009).
The laccase enzyme from Clitocybe maxima exhibited anti-
proliferative activity against Hep G2 and MCF-7 tumor
cells (Zhang et al. 2010a). The ethanolic extract of Clito-
cybe alexandri was found a very potent inhibitor of the
growth of lung, breast, colon, and gastric cancer cell lines
(Vaz et al. 2010). The ethanolic extract of this mushroom
exhibited significant potency against human lung cancer
(NCI-H460) cells. It was observed that the extract induced
an S-phase cell cycle arrest, increased the percentage of
apoptotic cells and enhanced the levels of p53. Cinnamic
acid was found to be the most potent compound regarding
cell-growth inhibition. It was verified that concomitant use
of the extract provided the strongest decrease in viable cell
number.
Albatrellus confluens
Albatrellus confluens is a polypore mushroom belonging to
the family Albatrellaceae. Grifolin, a secondary metabolite
isolated from the fresh fruiting bodies of A. confluens, has
been shown to inhibit the growth of some cancer cell lines
in vitro by up-regulating death-associated protein kinase 1
DAPK1 via p53 in nasopharyngeal carcinoma cells (Luo
et al. 2011). Ye et al. (2007) identified the novel targets of
grifolin by studying its effect on the human nasopharyngeal
carcinoma (CNE1) cell line. Following grifolin treatment, a
concomitant inhibition of cyclin D1, cyclin E, CDK4
expression, and subsequent reduction in pRB phosphory-
lation occurred. Meanwhile, grifolin treatment also resulted
in a significant up-regulation of CKI (p19INK4D). It proves
that both the ERK1/2 and the ERK5 pathways are involved
in the inhibition and significantly cause cell-cycle arrest in
G1 phase. Grifolin induces dephosphorylation and up-
regulates death-associated protein kinase 1 (DAPK1) in
nasopharyngeal carcinoma cells NPCs and HONE1. Grif-
olin promoted the protein–protein interaction of DAPK1
and ERK1/2 to prevent ERK1/2 nucleolus translocation.
Findings indicate that grifolin might represent a promising
candidate in the prevention and intervention of cancer by
targeting DAPK1 signaling to induce cell cycle G1 phase
arrest (Luo et al. 2011).
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Genus Russula
Ergosta-4,6,8(14),22-tetraen-3-one (ergone), a bioactive
steroid from Russula cyanoxantha has been demonstrated
to possess cytotoxic and anti-proliferative activity towards
HepG2 cells. Zhao et al. (2011) unraveled the molecular
mechanisms behind cytotoxic activity of ergone. HepG2
cells treated with ergone showed typical markers of
apoptosis: (a) G2/M cell cycle arrest, (b) chromatin con-
densation, (c) nuclear fragmentation, and (d) phosphatidyl-
serine exposure. Furthermore, PARP-cleavage; activation
of caspase-3, -8, and -9; up-regulation of Bax and down-
regulation of Bcl-2 were observed in HepG2 cells treated
with ergone. In this study, we reported for the first time that
ergone induced apoptosis through activating the caspase.
These results would be useful for the further utilization of
many medicinal fungi in cancer treatment. A lectin isolated
from Russula lepida exhibited anti-proliferative activity
toward Hep G2 cells and MCF-7 cells with an IC50 of
1.6 lM and 0.9 lM, respectively. Daily intraperitoneal
injections of the lectin (5.0 mg/kg) for 20 days brought
about 67.6% reductions in the weight of S-180 tumor
(Zhang et al. 2010b).
Fomes fomentarius
Chen et al. (2011) studied that ethanol extract of mycelial
biomass and intracellular polysaccharide of Fomes
fomentarius play crucial roles in gastric cancer intervention.
Both the extracts exhibit anti-proliferative effect on human
gastric cancer cell lines SGC-7901 and MKN-45 in a dose-
dependent manner. In contrast, human normal gastric cell
line GES-1 was less susceptible to EEM and IPS. These
results suggest that F. fomentarius may represent a prom-
ising novel approach for gastric cancer intervention. Fur-
thermore, the exopolysaccharide from this mushroom has a
direct anti-proliferative effect in vitro on SGC-7901 cells in
a dose- and time-dependent manner. Also, this exopoly-
saccharide sensitized doxorubicin (Dox) and induced
growth inhibition of SGC-7901 cells at noncytotoxic con-
centration of 0.25 mg/mL after 24 h treatment (Chen et al.
2008).
Piptoporus betulinus
Piptoporus betulinus, commonly known as the birch
polypore belonging to Fomitopsidaceae family has been
studied in vitro for its anti-cancer activity. The fraction
prepared from dried fruiting bodies was subjected to anti-
cancer evaluation in human lung carcinoma (A549), colon
adenocarcinoma (HT-29) and rat glioma (C6) cell cultures.
P. betulinus fraction elicited anti-cancer effects that were
attributed to decreased tumor cell proliferation, motility
and the induction of morphological changes. Moreover, it
produced no or low toxicity in tested normal cells (Lemi-
eszek et al. 2009).
Genus Antrodia
Antrodia (camphor tree mushroom) is a genus of mush-
rooms in the famly Fomitopsidaceae. These mushrooms are
highly valued in Taiwan. The fermented culture broth of
Antrodia camphorata has been shown to promote cell cycle
arrest and apoptosis of human estrogen-non-responsive
breast cancer (MDA-MB-231) cells. Yang et al. (2011) dem-
onstrated that non-cytotoxic concentrations (20–80 lg/mL)
of A. camphorata markedly inhibit the invasion/migration
of highly metastatic MDA-MB-231 cells through sup-
pression of the MAPK signaling pathway. Antroquinonol, a
ubiquinone derivative isolated from A. camphorata,
induced a concentration-dependent inhibition of cell pro-
liferation in pancreatic cancer (PANC-1 and AsPC-1) cells.
Flow cytometric analysis showed that antroquinonol
induced G1 arrest of the cell cycle and a subsequent
apoptosis. Antroquinonol induces anti-cancer activity in
human pancreatic cancers through an inhibitory effect on
PI3-kinase/Akt/mTOR pathways that in turn down-regu-
lates cell cycle regulators. The translational inhibition
causes G1 arrest of the cell cycle and an ultimate mito-
chondria-dependent apoptosis. Antroquinonol also induced
the cross talk between apoptosis, autophagic cell death and
accelerated senescence in cancer cells (Yu et al. 2011). The
solid-state extracts of A. camphorata, when combined with
anti-tumor agents showed adjuvant anti-proliferative
effects on hepatoma (C3A and PLC/PRF/5) cells and on
xenografted cells in tumor-implanted nude mice, extending
their median survival days. The inhibition effect was elu-
cidated to be through intervention of MDR gene expres-
sions and COX-2- dependent inhibition of p-AKT (Chang
et al. 2008). Peng et al. (2007) studied that the A. cam-
phorata crude extract has significant suppressive effects on
the growth and proliferation of the transitional cell carci-
nomas cell lines, the superficial cancer cell line RT4, and
metastatic cell lines, TSGH-8301 and T24. On treatment
with the extract at 100 lg/mL, the p53-independent over-
expression of p21 with simultaneous down alteration of
pRb was observed in RT4. On the contrary, treatment with
the extract, at 50 lg/mL, result in simultaneous down-
regulations of Cdc2 and Cyclin B1, with suppression of the
absolute migrating capability of the two cell lines TSGH-
8301 and T24, and eventually the cell deaths. A HPLC
fraction of alcohol extract isolated from A. camphorata
induced apoptosis in A549 cell by decreasing the expres-
sion level of four tumor-related genes, e.g., calpain 1/2
small subunit, galectin-1, Rho GDP inhibitor a and
eukaryotic translation initiation factor 5A. Apoptosis is
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triggered by the mitochondrial pathway and endothelium
reticulum stress. Fr-6 also could decrease the production
level of eukaryotic translation initiation factor 5A, which is
a potential cancer intervention target. Chan et al. (2010)
suggested that the anti-cancer activity of A. camphorata
might be due to multiple active metabolites, which work
together to induce cell apoptosis via various pathways.
Hseu et al. (2007) investigated the fermented culture broth
of A. camphorata to induce apoptosis and inhibit cyclo-
oxygenase-2 (COX-2) in MDA-MB-231 cancer cells.
Treatment of these cells with A. camphorata (40–240 lg/mL)
resulted in dose and time-dependent apoptosis, as evi-
denced by loss of cell viability, chromatin condensation,
and internucleosomal DNA fragmentation. Apoptosis in
the MDA-MB-231 cells was accompanied by release of
cytochrome c, activation of caspase-3, -8, and -9, and
specific proteolytic cleavage of poly (ADP-ribose) poly-
merase (PARP). Also, A. camphorata treatment inhibited
COX-2 protein expression and prostaglandin E2 (PGE2)
production in MDA-MB-231 cells. Fermented culture
broth of A. camphorata has been shown to induce apoptosis
in MDA-MB-231 cells in vitro and in vivo in nude mice.
Antrodia camphorata treatment decreased the proliferation
of canerous cells by arresting progression through the G1
phase of the cell cycle. Hseu et al. (2008) studied that cell
cycle blockade in A. camphorate-treated MDA-MB-231
cells was associated with reductions in cyclin D1, cyclin E,
CDK4, cyclin A, and proliferating cell nuclear antigen
(PCNA), and increased CDK inhibitor p27/KIP and p21 in
a dose- and time-dependent manner. 50AMP-activated
protein kinase (AMPK) and the mammalian target of rap-
amycin (mTOR) are two serine/threonine protein kinases
and potential targets for cancer chemotherapy against
hepatocellular carcinoma cells. Chiang et al. (2010) studied
that A. camphorate extract displayed effective anti-cancer
activity against both hepatitis B virus (HBV) DNA-positive
and -negative hepatocellular carcinoma cell lines (HepG2,
HepG2.2.15, Mahlavu, PLC/PRF/5, SK-Hep1 and Hep3B).
Antroquinonol completely abolished cell-cycle progression
and caused a subsequent apoptosis. The loss of mitochon-
drial membrane potential and depletion of mitochondrial
content indicated the mitochondrial stress caused by ant-
roquinonol. Antroquinonol displays anti-cancer activity
against the hepato carcinoma cells through AMPK activa-
tion and inhibition of mTOR translational pathway, leading
to G1 arrest of the cell-cycle and subsequent cell apoptosis.
Kumar et al. (2011) reported that antroquinonol treatment
significantly reduced the proliferation of A549 as evi-
denced from cell shrinkage, apoptotic vacuoles, pore for-
mation, TUNEL positive cells and increased Sub-G1 cell
population with respect to time and dose dependent man-
ner. Antroquinonol-induced apoptosis was associated with
disrupted mitochondrial membrane potential and activation
of caspase 3 and PARP cleavage in A549 cells. Moreover,
antroquinonol treatment down-regulated the expression of
apoptosis regulatory proteins Bcl2, which was correlated
with the decreased PI3K and mTOR protein levels without
altering pro apoptotic and anti apoptotic proteins. Ant-
roquinonol altered the expression level of miRNAs com-
pared with untreated control in A549 cells. The data
collectively suggested the anti-proliferative effect of ant-
roquinonol may be a promising chemotherapeutic agent for
lung cancer. Tsai et al. (2010) studied that methylantcinate
A (MAA), an ergostane type triterpenoid isolated from
A. camphorata inhibited the growth of oral cancer (OEC-
M1 and OC-2) cell lines in a dose-dependent manner,
without showing cytotoxicity to normal oral gingival
fibroblast cells. The mechanism of growth inhibition was
apoptosis induction, resultant of caspase-3 activation and
DNA fragmentation. Hsu et al. (2007) reported the anti-
invasive effect of ethyl acetate extract from Antrodia cin-
namomea fruiting bodies in the human liver cancer (PLC/
PRF/5) cell line. This effect was strongly associated with a
concomitant decrease in either the level or activity of
VEGF, matrix metalloproteinases (MMP-2, MMP-9 and
MT1-MMP), and an increase in the expression of tissue
inhibitor of metalloproteinase (TIMP-1 and TIMP-2). The
extract inhibited constitutively activated and inducible NF-
jB in both its DNA-binding activity and transcriptional
activity, also inhibited the TNF-a-activated NF-jB-
dependent reporter gene expression of MMP-9 and VEGF.
Angiogenesis assay showed that the extract also exhibited
an inhibitory effect on angiogenesis.
Polyozellus multiplex
A Korean wild mushroom Polyozellus multiplex checks
cell proliferation in stomach cancer by increased expres-
sion of p53 proteins (Lee and Nishikawa 2003). Polyozellin
isolated from this mushroom induces phase 2 detoxifying
enzymes with cancer-preventive potential in mouse hepa-
toma cells. Also, it significantly induced differentiation in
human myeloid leukaemic cell lines (Kim et al. 2004b).
Current scenario and future perspectives
Mushroom products are set to create a revolution in ther-
apeutic strategies in curbing various forms of cancers.
Several companies are dedicated to prepare anti-cancer
formulae from mushroom extracts using state-of-the-art
technology and their products are gradually being recog-
nized globally. Zhejiang Fangge Pharmaceutical &
Healthcare Products Co. Ltd., a large pharmaceutical
company in China specializes in development and mar-
keting of mushroom extracts for anti-cancer uses. The
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enterprise manufactures and exports polysaccharides from
mushrooms G. frondosa, L. edodes, G. lucidum, A. blazei,
Cordyceps sinensis and H. erinaceus. FineCo Ltd., an
emerging Korean company develops effective drugs,
including anti-cancer formulations from medicinal mush-
rooms. Its products are now sold in Japan, Hong Kong,
Australia, America, and Europe, for use in clinical test on
cancer patients. A pioneering mushroom company Mush-
room Wisdom, based in USA is engaged in formulating
supplements for inhibiting cancer. USA based Aloha
medicinal Inc. manufactures an array of medicinal mush-
room products including the cancer-inhibiting Ganoderma
capsules. In near future, more companies are expected to
join the flourishing market of cancer therapeutic manu-
facture from mushrooms. Better insight into the mecha-
nisms underlying biological action of mushroom will
accelerate commercial production of pharmaceuticals for
cancer therapy.
Conclusions
Medicinal mushrooms represent a growing segment of
today’s pharmaceutical industry owing to the plethora of
useful bioactive compounds. While they have a long his-
tory of use across diverse cultures, they are backed up by
reasonable scientific investigation now. The mycologists
around the world, firmly believe that a greater knowledge
of mushroom can ameliorate many forms of cancers at
various stages. Exploration of unique species with medic-
inal properties from the untapped wilderness is warranted.
Conservation and cloning of therapeutic mushrooms is
needed for sustainable development. Dedicated research
should be undertaken to isolate, purify and structural
investigation of novel anti-cancer and immune-stimulator
compounds. Studies to date have identified a number of
compounds and elucidated underlying mechanism. How-
ever, research is needed to elucidate the different roles of
multiple active compounds and the pathways involved.
These findings are important due to the lack of chemo-
therapeutic agents of some forms of malignant cancer, viz.
estrogen receptor negative human breast cancer, mesothe-
lioma, acute lymphocytic leukemia, acute myeloid leuke-
mia, Hodgkin lymphoma, hopeless astrocytoma, etc. The
present results and data might provide new insights into the
possible therapeutic uses of mushrooms and helpful sug-
gestions for the design of anti-tumor drugs from mush-
rooms in combating cancer.
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